An inside look at a molecular switch that triggers inflammation
Researchers at VIB and Ghent University have uncovered how an important driver of inflammation is activated at the molecular level. Their findings, published in Science Immunology, also explain how a medicine used to treat a severe form of psoriasis blocks this inflammatory signal.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Discontinuing statins generally safe for older adults without heart disease
United Kingdom
-
Intravenous antiplatelet therapy may improve heart function in cardiogenic shock patients compared to oral medication
United Kingdom
-
Five AI models tackled 227 pharmacy exam questions. Here's where they struggled
United Kingdom
-
Few meet major clinical response criteria after treatment escalation for lupus
United Kingdom
-
New blood test claims to detect 50+ cancers before symptoms—but there's no proof it reduces cancer death risk
United Kingdom
-
Scientists identify inhibition of a specific enzyme as a promising target to treat pancreatic cancer
United Kingdom
-
Researchers reveal how inhaled nanoplastics trigger lung inflammation
United Kingdom
-
Intensive blood pressure therapy did not cut cardiovascular events in adults with diabetes
United Kingdom